Ignite Creation Date:
2025-12-24 @ 11:48 AM
Ignite Modification Date:
2026-02-05 @ 1:47 PM
Study NCT ID:
NCT02545361
Status:
WITHDRAWN
Last Update Posted:
2018-08-16
First Post:
2015-08-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety, Tolerability, and Anti-cancer Activity of KAHR-102 (The Study Drug) for the Treatment of Lymphoma Patients
Sponsor:
Kahr Medical
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-04
Start Date Type:
ESTIMATED
Primary Completion Date:
2020-04
Primary Completion Date Type:
ESTIMATED
Completion Date:
2020-04
Completion Date Type:
ESTIMATED
First Submit Date:
2015-08-04
First Submit QC Date:
None
Study First Post Date:
2015-09-10
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-08-14
Last Update Post Date:
2018-08-16
Last Update Post Date Type:
ACTUAL